glp-1 modulation by probiotics scientific evidence Probiotic of Gut Microbiota: Antioxidant Mechanisms and Clinical Benefits in Obesity and Type 2 Diabetes Management Frontiers | A comprehensive overview

They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such

The authors suggested that insurance barriers, cultural beliefs and concerns about side effects may play a role in this discrepancy, echoing findings from prior research showing lower uptake of GLP-1 RAs among black, Hispanic and Asian patients

This hypothesis has been supported by studies in mice, rats, and non-human primates, demonstrating -syn propagation from the periphery to the central nervous system (CNS) and vice versa, as well as from the brain to other organs (Luk et al., 2012

SGLT2 inhibitors and metformin are often used alongside GLP-1 therapy because they work through distinct mechanisms, offering additional benefits like weight loss and improved cardiovascular health

However, it alone does not confirm every quality factor

doi:10.3390/ani10101855